ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool
Start-ups and commercialisation at ELRIG Drug Discovery 2026
Oct 14–15, 2026 London, UK ~3k attendees Website
42 organizations at ELRIG Drug Discovery 2026 present work in start-ups and commercialisation: 30 technology and service providers, 9 academic, government and non-profit bodies and 3 drug developers. Between them they bring 21 presentations to the program. Most represented: LifeArc, Ignota Labs and Cancer Research Horizons. As of Oct 8, 2026.
Format
Top represented
Showing 1–18 of 42 organizations
| Organization | ELRIG Drug Discovery 2026 Attendance |
|---|---|
LifeArc London, UK | ◆Partner |
UK medical research charity that funds and runs translational research and drug discovery to move science toward patients. | Booth Exhibiting at Booth CZ03 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 9:20am–9:25am Talk Wed Oct 14 9:25am–10:10am |
Ignota Labs Cambridge, UK | |
AI company rescuing failed or shelved drug candidates by solving safety problems and creating new chemistry and IP. | Talk Thu Oct 15 12:40pm–1:10pm Panel Thu Oct 15 3:30pm–4:00pm |
Cancer Research Horizons London, UK | |
Innovation arm of Cancer Research UK, turning academic cancer research into drugs, diagnostics and start-ups through partnerships and licensing. | Booth Exhibiting at Booth C24 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Targeted potency: Advances in radioligands and bioconjugates How radioligand therapies and bioconjugates deliver toxic payloads more precisely and safely to cancers that were once hard to treat. |
Medicines Discovery Catapult Alderley Park, UK | |
UK national centre helping drug discovery entrepreneurs validate ideas and de-risk investment through its expertise, technology and national programmes. | Booth Exhibiting at Booth G28 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 4:15pm–4:30pm Advancing Drug Discovery Through Radiopharmaceutical Innovation Why radioactive drugs that both image and treat tumours can confirm a drug reaches its target, and what manufacturing hurdles remain. |
Creasallis Cambridge, UK | |
Develops a modification that helps antibodies and conjugates penetrate deeper into solid tumours, alongside its own oncology antibody programs. | Talk Thu Oct 15 3:00pm–3:30pm Panel Thu Oct 15 3:30pm–4:00pm |
M MFX Stevenage, UK | |
Builds a closed, parallel instrument with continuous online monitoring for early cell therapy process development. | Talk Thu Oct 15 2:30pm–3:00pm Panel Thu Oct 15 3:30pm–4:00pm |
Bioicus Lab Harwell, UK | |
Consultancy building workflows, quality systems and product leadership to take life science discoveries to market; also manages licensable biological assets. | Consultancy Café table Talk Thu Oct 15 12:25pm–12:40pm |
Amadeus Capital Partners London, UK | |
Venture capital firm backing early-stage deep-technology companies. | Panel Thu Oct 15 12:25pm–1:10pm |
AB Amilon Bio Cambridge, UK | |
Venture creation company that builds biotech businesses from in-house ideas and external opportunities. | Chair Thu Oct 15 10:50am–10:55am Track Chair- Innovation Zone How early-stage life science companies raise money, carry discoveries toward market and build portfolios, and where such efforts commonly fail. |
CI Cam Innovations | |
Talk Thu Oct 15 11:25am–11:55am | |
CellCodex Cambridge, UK | |
Generates causal cell-perturbation data for AI drug discovery, using genome-wide screens in aged, disease-relevant human cell models. | Talk Thu Oct 15 10:55am–11:25am |
GN Gris Noir | |
Talk Thu Oct 15 11:55am–12:25pm | |
Isomorphic Labs London, UK | |
AI drug discovery company, spun out of Google DeepMind, building predictive models to design new medicines. | Chair Thu Oct 15 10:50am–10:55am Track Chair- Innovation Zone How early-stage life science companies raise money, carry discoveries toward market and build portfolios, and where such efforts commonly fail. |
Macmillan Cancer Support London, UK | |
UK cancer support charity with a venture investment arm, Macmillan Ventures. | Panel Thu Oct 15 12:25pm–1:10pm |
Specialist healthcare fund manager investing in life science and healthcare companies across stages. | Panel Thu Oct 15 12:25pm–1:10pm |
Mathys & Squire London, UK | |
Full-service intellectual property firm handling patents, trade marks, designs and litigation for technology-rich businesses. | Innovation Prize sponsor Workshop sponsor Workshop Thu Oct 15 1:25pm–2:05pm |
Regulatory affairs consultancy offering interim senior leadership, global development strategy and mentoring to biotech and pharma companies. | Consultancy Café table |
Atomixel London, UK | |
Independent consultancy advising life science firms on which tools to adopt or build, drawing on microfluidics, single-cell and product development expertise. | Consultancy Café table |
Instantly find 20 buyers in start-ups and commercialisation
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ELRIG Drug Discovery 2026 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by ELRIG. Submit a correction